Biodexa Pharmaceuticals (BDRX)

AI Score

Unlock

1.45

0.05 (3.57%)

At close: Apr 23, 2025, 3:59 PM

1.39

-3.65%

Pre-market: Apr 24, 2025, 04:53 AM EDT

Dividends

No dividend history available for Biodexa Pharmaceuticals.

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

BDRX News

1 month ago · With Fast Track Designation in Hand, a Successful Protocol Discussion with FDA, and CROs in Place, Biodexa is on Track to Initiate its Funded Phase 3 Trial in FAP Next Quarter - accessnewswire.com
2 months ago · Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status - accessnewswire.com